Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma

Japanese Journal of Clinical Oncology

Volumn 32, Issue 2, 2002, Pages 54-58

  Ito, Katsuki ^a   Hibi, Kenji ^a   Ando, Hideyuki ^a   Hidemura, Kazuhiko ^a   Yamazaki, Taiji ^a   Akiyama, Seiji ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinoembryonic antigen (CEA); Colorectal carcinoma; Doubling time; Micrometastases, half life time

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; ENZYME IMMUNOASSAY; FEMALE; HALF LIFE TIME; HUMAN; MALE; METASTASIS; PREOPERATIVE EVALUATION; PROGNOSIS; ADRENAL TUMOR; BLOOD; COLON TUMOR; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FEMALE; HALF-LIFE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036480632     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyf011     Document Type: Article

References (31)

1. Castells A, Boix L, Bessa X, Gargallo L, Pique JM. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998;78:1368-72.
2. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34.
3. Edmiston KH, Gangopadhyay A, Shoji Y, Nachman AP, Thomas P, Jessup JM. In vivo induction of murine cytokine production by carcinoembryonic antigen. Cancer Res 1997;57:4432-6.
4. Jessup JM, Ishii S, Mitzoi T, Edmiston KH, Shoji Y. Carcinoembryonic antigen facilitates experimental metastasis through a mechanism that does not involve adhesion to liver cells. Clin Exp Metastasis 1999;17:481-8.
5. Leconte A, Garambois V, Ychou M, Robert B, Pourquier D, Terskikh A, et al. Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. Br J Cancer 1999;80:1373-9.
6. Kim JC, Gong G, Roh SA, Park KC. Carcinoembryonic antigen gene and Carcinoembryonic antigen expression in the liver metastases of colorectal carcinoma. Mol Cells 1999;9:133-7.
7. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
8. Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238-43.
9. Alvarez JA, Marin J, Jover JM, Fernandez R, Fradejas J, Moreno M. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50 and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma. Dis Colon Rectum 1995;38:535-42.
10. Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66:238-43.
11. Morales-Gutierrez C, Vegh I, Colina F, Gomez-Camara A, Landa JI, Ballesteros D, et al. Survival of patients with colorectal carcinoma: possible prognostic value of tissular carbohydrate antigen 19.9 determination. Cancer 1999;86:1675-81.
12. Albanopoulos K, Armakolas A, Konstadoulakis MM, Leandros E, Tsiobanou E, Katsaragakis S, et al. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer. Am J Gastroenterol 2000;95:1056-61.
13. Bhatnagar J, Tewari HB, Bhatnagar M, Austin GE. Comparison of carcinoembryonic antigen in tissue and serum with grade and stage of colon cancer. Anticancer Res 1999;19:2181-7.
14. Molina R, Farms B, Filella X, Jo J, Zanon G, Pahisa J, et al. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse. Anticancer Res 1999;19:2557-62.
15. Kassis ES, Nguyen N, Shriver SP, Siegfried JM, Schauer PR, Luketich JD. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques. J Soc Laparoendosc Surg 1999;2:331-6.
16. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, et al. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128-32.
17. Zhong XY, Kaul S, Thompson J, Eichler A, Bastert G. Evaluation of the reverse transcriptase/polymerase chain reaction for carcinoembryonic antigen for the detection of breast cancer dissemination in bone marrow and peripheral blood. J Cancer Res Clin Oncol 1999;125:669-74.
18. Miyake Y, Fujiwara Y, Ohue M, Yamamoto H, Sugita Y, Tomita N, et al. Quantification of micrometastases in lymph nodes of colorectal cancer using real-time fluorescence polymerase chain reaction. Int J Oncol 2000;16:289-93.
19. Gibaldi M, Perrier D. Pharmacokinetics. In: Swarbrick J, ed. Drugs and the Pharmaceutical Sciences New York, 1975;Marcel Dekker, 1-5.
20. Gold P, Freedman SO. Demonstration of tumour-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-62.
21. Rockall TA, McDonald PJ. Carcinoembryonic antigen: its value in the follow-up of patients with colorectal cancer. Int J Colorectal Dis 1999;14:73-7.
22. Chapman MA, Buckley D, Henson DB, Armitage NC. Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer 1998;78:1346-9.
23. Forones NM, Tanaka M. CEA and CA 19-9 as prognostic indexes in colorectal cancer. Hepato-Gastroenterology 1999;46:905-8.
24. Tuxen MK, Sölétormos G, Petersen PH, Schiøler V, Dombernowsky P. Assessment of biological variation and analytical imprecision of CA 125, CEA and TPA in relation to monitoring of ovarian cancer. Gynecol Oncol 1999;74:12-22.
25. MacKay AM, Patel S, Carter S, Stevens U, Laurence DJ, Cooper EH, et al. Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomas. Br Med J 1974;4:382-5.
26. Ravry M, Moertel CG, Schutt AJ, Go VL. Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer 1974;34:1230-4.
27. Sugarbaker PH, Skarin AT, Zamcheck N. Patterns of serial CEA assays and their clinical use in management of colorectal cancer. J Surg Oncol 1976;8:523-37.
28. Staab HJ, Anderer FA, Stumpf E, Fischer R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg 1978;136:322-7.
29. Wood CB, Ratcliffe JG, Burt RW, Malcolm AJH, Blumgart LH. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg 1980;67:46-8.
30. Yamada K, Ishizawa T, Nakano S, Haruyama K, Katsura Y, Hase S, et al. Clinicopathological features of colorectal cancer with liver or lung metastasis and carcinoembyonic antigen doubling time in the course of the disease. Jpn J Gastroenterol Surg 1989;22:2660-5.
31. Staab HJ, Anderer FA, Hornung A, Stumpf E, Fischer R. Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancer. Br J Cancer 1982;46:773-81.